ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

AKRO Akero Therapeutics Inc

28.12
-0.20 (-0.71%)
取引時間後
最終更新日: 06:30:00
15分遅延
名称 銘柄コード 市場 種別
Akero Therapeutics Inc AKRO NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.20 -0.71% 28.12 06:30:00
始値 安値 高値 終値 前日終値
28.65 28.09 29.12 28.12 28.32
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/7/2606:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/7/2505:25EDGAR2Form 144 - Report of proposed sale of securities
2024/7/1910:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/7/1705:04EDGAR2Form 144 - Report of proposed sale of securities
2024/6/1407:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1407:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1407:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1407:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1407:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1407:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1306:23EDGAR2Form 8-K - Current report
2024/6/1206:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1206:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1206:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1206:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1120:00GLOBEAkero Therapeutics Announces Initiation of Phase 3 SYNCHRONY..
2024/6/0821:15GLOBEAkero Therapeutics Presents Poster and Late-breaking Oral..
2024/6/0606:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/2920:00GLOBEAkero Therapeutics to Present at the Jefferies Global..
2024/5/1105:57EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/5/1020:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/1020:17EDGAR2Form 8-K - Current report
2024/5/1020:00GLOBEAkero Therapeutics Reports First Quarter 2024 Financial..
2024/5/0820:00GLOBEAkero Therapeutics to Present at the BofA Securities 2024..
2024/4/3021:00GLOBEAkero Therapeutics Appoints Scott Gangloff as Chief..
2024/3/0906:02GLOBEAkero Therapeutics Announces Closing of Public Offering of..
2024/3/0806:01GLOBEAkero Therapeutics Announces Publication of Phase 2b..
2024/3/0710:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0710:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0707:25EDGAR2Form 8-K - Current report
2024/3/0707:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0611:13GLOBEAkero Therapeutics Announces Pricing of Public Offering of..
2024/3/0607:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0520:05IHMARKETNEWSAMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on..
2024/3/0507:34EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0507:30EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0507:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0506:21GLOBEAkero Therapeutics Announces Proposed Public Offering of..
2024/3/0421:55EDGAR2Form 8-K - Current report
2024/3/0420:00GLOBEAkero Therapeutics Reports Statistically Significant..
2024/3/0106:42EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2922:00GLOBEAkero Therapeutics to Present Topline Week 96 Results from..
2024/2/2921:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2921:15EDGAR2Form 8-K - Current report
2024/2/2921:00GLOBEAkero Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/2/1411:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0322:15GLOBEAkero Therapeutics to Present at the 42nd Annual J.P. Morgan..
2023/12/3010:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/3008:07EDGAR2Form 144 - Report of proposed sale of securities

最近閲覧した銘柄

Delayed Upgrade Clock